Biotech · Private company
LAPIX Therapeutics Inc.
Track this companyFree. Adds LAPIX Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- LPX-TI641Phase 1 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
- LPX-TI641Phase 1 · Autoimmune DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- LPX-TI641Phase 1 · Rheumatoid Arthritis (RA)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisPHASE1 · RECRUITING · started Jun 15, 2025ClinicalTrials.gov NCT06982352 · fetched Nov 12, 2026
- Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic ArthritisPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 15, 2024ClinicalTrials.gov NCT06628206 · fetched Nov 12, 2026
- First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641PHASE1 · COMPLETED · started Oct 30, 2023ClinicalTrials.gov NCT05853835 · fetched Nov 12, 2026
- An Observational Biomarker Study in Multiple Sclerosis (MS) PatientsCOMPLETED · started Mar 28, 2023ClinicalTrials.gov NCT05663853 · fetched Nov 12, 2026